225 related articles for article (PubMed ID: 23456231)
1. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy.
Rodin D; Sutradhar R; Nofech-Mozes S; Gu S; Faught N; Hahn E; Fong C; Trebinjac S; Paszat L; Rakovitch E
Breast Cancer Res Treat; 2022 Feb; 192(1):223-233. PubMed ID: 35083587
[TBL] [Abstract][Full Text] [Related]
3. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.
Pawloski KR; Tadros AB; Sevilimedu V; Newman A; Gentile L; Zabor EC; Morrow M; Van Zee KJ; Kirstein LJ
Breast Cancer Res Treat; 2021 Apr; 186(3):617-624. PubMed ID: 33675490
[TBL] [Abstract][Full Text] [Related]
4. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
Rakovitch E; Gray R; Baehner FL; Sutradhar R; Crager M; Gu S; Nofech-Mozes S; Badve SS; Hanna W; Hughes LL; Wood WC; Davidson NE; Paszat L; Shak S; Sparano JA; Solin LJ
Breast Cancer Res Treat; 2018 Jun; 169(2):359-369. PubMed ID: 29388015
[TBL] [Abstract][Full Text] [Related]
5. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.
Chien JC; Liu WS; Huang WT; Shih LC; Liu WC; Chen YC; Chou KJ; Shiue YL; Lin PC
Breast; 2022 Jun; 63():29-36. PubMed ID: 35299032
[TBL] [Abstract][Full Text] [Related]
6. Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands.
Luiten JD; Luiten EJT; van der Sangen MJC; Vreuls W; Duijm LEM; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2021 May; 187(1):245-254. PubMed ID: 33385265
[TBL] [Abstract][Full Text] [Related]
7. Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences.
Bartholomew K; Ghafel M; Tin Tin S; Aye PS; Elwood JM; Hardie C; Scott N; Kidd J; Ramsaroop R; Campbell I
BMC Cancer; 2023 Aug; 23(1):766. PubMed ID: 37592208
[TBL] [Abstract][Full Text] [Related]
8. Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective.
Bijker N; van Tienhoven G
J Natl Cancer Inst Monogr; 2010; 2010(41):178-80. PubMed ID: 20956825
[TBL] [Abstract][Full Text] [Related]
9. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
Alaeikhanehshir S; Schmitz RSJM; van den Belt-Dusebout AW; van Duijnhoven FH; Verschuur E; van Seijen M; Schaapveld M; Lips EH; Wesseling J;
Breast Cancer Res Treat; 2024 Feb; 204(1):61-68. PubMed ID: 37964135
[TBL] [Abstract][Full Text] [Related]
10. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
Schmitz RSJM; van den Belt-Dusebout AW; Clements K; Ren Y; Cresta C; Timbres J; Liu YH; Byng D; Lynch T; Menegaz BA; Collyar D; Hyslop T; Thomas S; Love JK; Schaapveld M; Bhattacharjee P; Ryser MD; Sawyer E; Hwang ES; Thompson A; Wesseling J; Lips EH; Schmidt MK;
BMJ; 2023 Oct; 383():e076022. PubMed ID: 37903527
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of DCIS treated with breast conserving surgery without radiotherapy on recurrence, survival, and health-related quality of life.
Fitzpatrick SE; Eaton M; McLeay W; Dean NR
ANZ J Surg; 2023 Sep; 93(9):2208-2213. PubMed ID: 37062870
[TBL] [Abstract][Full Text] [Related]
12. Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.
Shumway DA; McLeod CM; Morrow M; Li Y; Kurian AW; Sabolch A; Hamilton AS; Ward KC; Katz SJ; Hawley ST; Jagsi R
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1237-1245. PubMed ID: 29439886
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.
Stuart KE; Houssami N; Taylor R; Hayen A; Boyages J
BMC Cancer; 2015 Nov; 15():890. PubMed ID: 26555555
[TBL] [Abstract][Full Text] [Related]
14. Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
van Seijen M; Lips EH; Fu L; Giardiello D; van Duijnhoven F; de Munck L; Elshof LE; Thompson A; Sawyer E; Ryser MD; Hwang ES; Schmidt MK; Elkhuizen PHM; ; Wesseling J; Schaapveld M
Br J Cancer; 2021 Nov; 125(10):1443-1449. PubMed ID: 34408284
[TBL] [Abstract][Full Text] [Related]
15. A low risk of recurrence after breast-conserving surgery for DCIS: A single-institution experience.
van Bekkum S; Drukker C; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Cancer Treat Res Commun; 2023; 35():100706. PubMed ID: 37058969
[TBL] [Abstract][Full Text] [Related]
16. Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?
Livingston-Rosanoff D; Trentham-Dietz A; Hampton JM; Newcomb PA; Wilke LG
Breast Cancer Res Treat; 2021 Sep; 189(2):463-470. PubMed ID: 34129117
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).
Kuo SH; Tseng LM; Chen ST; Sagara Y; Chang YC; Yeh HT; Kuo YL; Hung CC; Lu TP; Lee YH; Toi M; Huang CS
BMC Cancer; 2023 Sep; 23(1):865. PubMed ID: 37710198
[TBL] [Abstract][Full Text] [Related]
18. DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.
Rakovitch E; Parpia S; Koch A; Grimard L; Soliman H; Stevens C; Perera F; Kong I; Senthelal S; Anthes M; Wiebe E; Cao J; Goldberg M; Smith S; Spadafora L; Whelan TJ
Breast Cancer Res Treat; 2021 Jul; 188(1):133-139. PubMed ID: 33830392
[TBL] [Abstract][Full Text] [Related]
19. The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.
Marinovich ML; Azizi L; Macaskill P; Irwig L; Morrow M; Solin LJ; Houssami N
Ann Surg Oncol; 2016 Nov; 23(12):3811-3821. PubMed ID: 27527715
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.
Dick AW; Sorbero MS; Ahrendt GM; Hayman JA; Gold HT; Schiffhauer L; Stark A; Griggs JJ
J Natl Cancer Inst; 2011 Jan; 103(2):92-104. PubMed ID: 21200025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
